Sector portfolio · VC firm · South Korea
Korea Investment Partners' Biotech portfolio
Korea Investment Partners has backed 17 Biotech startups in rounds we track, $593M between them, shown by the stage each has reached. The best-funded is Virogin Biotech.
Korea Investment Partners's whole portfolioKorea Investment Partners's profile
Funding by segment
- Series B$172M5
- Stage not reported$144M5
- Series A$64M4
- Series C and later$214M3
Where they are based
- South Korea6$112M
- United States5$196M
- United Kingdom1$46M
- France1$13M
- Canada1$120M
- Belgium1$77M
- Australia1$16M
South Korea
United States
United Kingdom
France
Canada
Belgium
AustraliaFounded
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M12
- $50M to $250M4
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 17 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- South Korea6
- United States5
- United Kingdom1
- France1
- Canada1
- Belgium1
- Australia1
Startups by country, 7 countries in all.
Segment by segment
Series B
5 startups · $172M raised
OncoMyx TherapeuticsOncoMyx Therapeutics is a biotechnology company based in Phoenix, Arizona, founded in 2018.United States$75M
ProkariumProkarium is a clinical-stage biopharmaceutical company based in London, UK, focused on pioneering microbial immunotherapy for canUnited Kingdom$46M
CaremediCaremedi is a wearable drug pump and healthcare company.South Korea$20M
ImmunoBiomeImmunoBiome is a biotech company developing microbiome therapeutics to treat incurable diseases like autoimmune diseases.South Korea$18M
PDC*line PharmaPDC*line Pharma is a clinical-stage biotechnology company founded in 2014, specializing in the development of therapeutic cancer vaccines.France$13M
Stage not reported
5 startups · $144M raised
EloxxEloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.United States$66M
GencurixGencurix develops various diagnostic products to support precision medicine.South Korea$24M
Doosan Mobility InnovationDoosan Mobility Innovation (DMI) is a South Korean company and a subsidiary of the Doosan Group, established in 2016.South Korea$22M
ABL BioABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.South Korea$18M- PIPharos iBio Co.Pharos iBio Co.-$13M
Series A
4 startups · $64M raised
Actym Therapeutics, Inc.Actym Therapeutics, Inc.United States$26M
Geneos TherapeuticsGeneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.United States$16M- BBioPharmXBioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing products that treat chroniUnited States$14M
TSD Life SciencesTSD Life Sciences is a South Korean biotech company established in 2016, specializing in the development of cancer therapies and cSouth Korea$8.8M
Series C and later
3 startups · $214M raised
Virogin BiotechVirogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada.Canada$120M
UnivercellsUnivercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutionsBelgium$77M
SkylabsSkylabs is a business consulting company that specializes in digital marketing and quality assurance.Australia$16M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Korea Investment Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Korea Investment Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.